- Home
- TCX vs AQST Comparison
TCX vs AQST Comparison
Compare TCX & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCX
- AQST
- Stock Information
- Founded
- TCX 1992
- AQST 2004
- Country
- TCX Canada
- AQST United States
- Employees
- TCX N/A
- AQST N/A
- Industry
- TCX EDP Services
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- TCX Technology
- AQST Health Care
- Exchange
- TCX Nasdaq
- AQST Nasdaq
- Market Cap
- TCX 215.1M
- AQST 254.1M
- IPO Year
- TCX 1996
- AQST 2018
- Fundamental
- Price
- TCX $16.47
- AQST $2.51
- Analyst Decision
- TCX
- AQST Strong Buy
- Analyst Count
- TCX 0
- AQST 6
- Target Price
- TCX N/A
- AQST $11.17
- AVG Volume (30 Days)
- TCX 38.0K
- AQST 1.4M
- Earning Date
- TCX 05-08-2025
- AQST 05-06-2025
- Dividend Yield
- TCX N/A
- AQST N/A
- EPS Growth
- TCX N/A
- AQST N/A
- EPS
- TCX N/A
- AQST N/A
- Revenue
- TCX $362,275,000.00
- AQST $57,561,000.00
- Revenue This Year
- TCX N/A
- AQST N/A
- Revenue Next Year
- TCX N/A
- AQST $39.51
- P/E Ratio
- TCX N/A
- AQST N/A
- Revenue Growth
- TCX 6.76
- AQST 13.79
- 52 Week Low
- TCX $13.27
- AQST $2.20
- 52 Week High
- TCX $26.48
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- TCX 49.13
- AQST 41.88
- Support Level
- TCX $15.30
- AQST $2.20
- Resistance Level
- TCX $16.74
- AQST $2.61
- Average True Range (ATR)
- TCX 1.08
- AQST 0.22
- MACD
- TCX 0.08
- AQST -0.03
- Stochastic Oscillator
- TCX 78.24
- AQST 36.47
About TCX Tucows Inc.
Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.